DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Enanta Pharmaceuticals, Inc. (ENTA)
« Back to company indexENTA Chatter Timeline
Stock Ticker for ENTA
Most Active Tweeters for ENTA
No tweets foundRecent Tweets for ENTA
 |
@EnterpriseLeade Nathalie Adda Sells 4,155 Shares of Enanta Pharmaceuticals Inc $ENTA Stock https://t.co/wg1RyYzqbS August 21st 2018, 11:08pm |
 |
@dispatchtribune Insider Selling: Enanta Pharmaceuticals Inc $ENTA VP Sells 4,155 Shares of Stock https://t.co/SD8m68bIj3 August 21st 2018, 11:08pm |
 |
@InsiderAlertsIA $ENTA: New Insider Filing on Sr. VP & Chief Medical Officer NATHALIE ADDA: https://t.co/6TYwnTvp28 August 21st 2018, 10:08pm |
|
@EnterpriseLeade Bowling Portfolio Management LLC Purchases New Stake in Enanta Pharmaceuticals Inc $ENTA https://t.co/NVdWnOjMdl August 21st 2018, 5:08pm |
 |
@beyond_ninety Enanta Pharmaceuticals $ENTA Shareholder Krensavage Asset Management Has Lowered Position as Share Value Rose; As V… https://t.co/QApsDWxOLC August 21st 2018, 3:08pm |
 |
@usindexlive Krensavage Asset Management Has Decreased Its Enanta Pharmaceuticals $ENTA Holding; Emc Insurance Group $EMCI's Sen… https://t.co/8nMVCSRNVJ August 20th 2018, 2:08pm |
 |
@registrarjourn Enanta Pharmaceuticals $ENTA Downgraded by Zacks Investment Research https://t.co/i5aK8kqQgi August 20th 2018, 11:08am |
|
@EnterpriseLeade Enanta Pharmaceuticals $ENTA Downgraded by Zacks Investment Research https://t.co/rPOy1QnwnR August 20th 2018, 11:08am |
|
@registrarjourn Enanta Pharmaceuticals $ENTA Upgraded to Buy by Zacks Investment Research https://t.co/7waDpUgfgR August 20th 2018, 3:08am |
|
@EnterpriseLeade Enanta Pharmaceuticals $ENTA Upgraded to Buy by Zacks Investment Research https://t.co/gRoM6a0IdK August 20th 2018, 3:08am |
 |
@DewDiligence $ENTA also has considerable buyout vig. https://t.co/MjQv2esjUb August 19th 2018, 9:08pm |
 |
@tgtxdough $ENTA catalysts: (1) ongoing Mavyret/Maviret launch (2018)initiation of ph.II proof-of-concept study for EDP-938 in… https://t.co/Ztog33y4lC August 19th 2018, 2:08pm |
|
@registrarjourn Enanta Pharmaceuticals $ENTA Upgraded at Zacks Investment Research https://t.co/SdiyBKCe94 August 19th 2018, 1:08pm |
|
@EnterpriseLeade Enanta Pharmaceuticals $ENTA Upgraded at Zacks Investment Research https://t.co/bYgYyhaDxn August 19th 2018, 1:08pm |
 |
@bibeypost_stock As Enanta Pharmaceuticals INC $ENTA Stock Price Rose, Holder Matarin Capital Management LLC Cut Its Holding - https://t.co/MSYWIksGat August 19th 2018, 12:08pm |
 |
@reurope_stock Matarin Capital Management LLC Has Lowered Its Position in Enanta Pharmaceuticals INC $ENTA as Stock Price Rose https://t.co/S34HW9EOXg August 19th 2018, 12:08pm |
 |
@The_CasualSmart As Enanta Pharmaceuticals INC $ENTA Stock Value Rose, Shareholder Matarin Capital Management LLC Cut Its Position… https://t.co/QD337l6m3e August 19th 2018, 12:08pm |
 |
@mmahotstuff1 As Enanta Pharmaceuticals INC $ENTA Stock Rose, Matarin Capital Management LLC Lowered Its Stake by $5.13 Billion - https://t.co/y1ayheuQoK August 19th 2018, 12:08pm |
 |
@whatsonthorold2 As Enanta Pharmaceuticals INC $ENTA Market Value Rose, Matarin Capital Management LLC Has Cut Its Holding - https://t.co/O0ujIE5qAz August 19th 2018, 12:08pm |
 |
@west_moreland Matarin Capital Management LLC Lowered Enanta Pharmaceuticals INC $ENTA Stake as Stock Value Rose https://t.co/bA1zzVGCVT August 19th 2018, 12:08pm |
|
@The_CasualSmart Enanta Pharmaceuticals INC $ENTA Stock Value Rose While Matarin Capital Management LLC Has Lowered Holding by $5.1… https://t.co/deQQtFmEvp August 19th 2018, 12:08pm |
 |
@Fanob_stock Enanta Pharmaceuticals INC $ENTA Shareholder Matarin Capital Management LLC Trimmed Stake https://t.co/yBsNyde91P August 19th 2018, 12:08pm |
 |
@MareaInformativ Enanta Pharmaceuticals $ENTA Stock Rating Lowered by Zacks Investment Research https://t.co/I1WE7sIHhb August 19th 2018, 8:08am |
|
@MareaInformativ Enanta Pharmaceuticals $ENTA Stock Rating Upgraded by Zacks Investment Research https://t.co/iAZxubpTPk August 18th 2018, 11:08pm |
 |
@ThisLincolnian Enanta Pharmaceuticals $ENTA Given a $100.00 Price Target at Oppenheimer https://t.co/eaLuaTS6Ef August 18th 2018, 12:08pm |
|
@usindexlive Krensavage Asset Management Has Cut Its Enanta Pharmaceuticals $ENTA Stake by $10.16 Million; Shares Rose; Cincinna… https://t.co/5DWtQqik0m August 18th 2018, 11:08am |
|
@MareaInformativ Enanta Pharmaceuticals $ENTA Downgraded by Zacks Investment Research https://t.co/kGiVYzNIrR August 18th 2018, 10:08am |
|
@MareaInformativ Enanta Pharmaceuticals Inc $ENTA Expected to Announce Earnings of $1.16 Per Share https://t.co/AlFvoMmlFI August 18th 2018, 7:08am |
|
@EnterpriseLeade Enanta Pharmaceuticals Inc $ENTA Position Lifted by Acadian Asset Management LLC https://t.co/4lV87xoAFC August 17th 2018, 8:08pm |
 |
@dakotafinancial Oppenheimer Reiterates “$100.00” Price Target for Enanta Pharmaceuticals $ENTA https://t.co/DBSQKHflxP August 17th 2018, 5:08pm |
|
@DewDiligence $ENTA —Mavyret NRx% and TRx% hit all-time highs again in wk ending 8/10/18, according2 IMS: https://t.co/ijwZByKGsz https://t.co/AUWxjge6S4 August 17th 2018, 11:08am |
|
@registrarjourn Enanta Pharmaceuticals $ENTA Lowered to “Hold” at BidaskClub https://t.co/vJkHBNT8v3 August 16th 2018, 11:08pm |
|
@EnterpriseLeade Enanta Pharmaceuticals $ENTA Lowered to “Hold” at BidaskClub https://t.co/rjgrgULoYs August 16th 2018, 11:08pm |
|
@registrarjourn Somewhat Favorable Press Coverage Somewhat Unlikely to Affect Enanta Pharmaceuticals $ENTA Stock Price https://t.co/ucbCG2QxQr August 16th 2018, 10:08pm |
|
@EnterpriseLeade Somewhat Favorable Press Coverage Somewhat Unlikely to Affect Enanta Pharmaceuticals $ENTA Stock Price https://t.co/jdrZLt771s August 16th 2018, 10:08pm |
|
@ThisLincolnian Brokerages Expect Enanta Pharmaceuticals Inc $ENTA Will Post Earnings of $1.14 Per Share https://t.co/CZe1nzv56f August 16th 2018, 4:08pm |
 |
@ConsumerFeed $66.35 Million in Sales Expected for Enanta Pharmaceuticals Inc $ENTA This Quarter https://t.co/5gc13B4LKx August 16th 2018, 4:08pm |
 |
@TranscriptDaily Enanta Pharmaceuticals $ENTA Given a $100.00 Price Target by Oppenheimer Analysts https://t.co/7iFdM7zcPS August 16th 2018, 4:08pm |
 |
@dogwhistles $ENTA coolly back in the 90s, up 4% for the day atm. August 16th 2018, 11:08am |
|
@beyond_ninety Farallon Capital Management Llc Increased Enanta Pharmaceuticals $ENTA Stake by $18.40 Million; Mainstay Mackay Def… https://t.co/qv1ktxncmz August 16th 2018, 10:08am |
 |
@LargeVoidBot Daily Reversal (10:08): $ENTA Last: 91.10; pHigh: 90.53; rVol: 0.424; pClose: 87.99; LOD: 87.9900; Perf: 3.5% August 16th 2018, 10:08am |
|
@EnterpriseLeade Enanta Pharmaceuticals $ENTA Issues Quarterly Earnings Results https://t.co/HXa5PJGbEz August 15th 2018, 10:08pm |
|
@MareaInformativ Enanta Pharmaceuticals $ENTA Issues Quarterly Earnings Results https://t.co/PNtgzyF3f5 August 15th 2018, 9:08pm |
 |
@ZolmaxNews Enanta Pharmaceuticals $ENTA Given a $100.00 Price Target by Oppenheimer Analysts https://t.co/mOtLbarYi9 August 15th 2018, 3:08pm |
 |
@bbnsnews Enanta Pharmaceuticals Inc $ENTA Receives Consensus Recommendation of “Hold” from Brokerages https://t.co/O398jzLGSM August 15th 2018, 12:08pm |
 |
@AmericanBanking Enanta Pharmaceuticals Inc $ENTA Receives Average Recommendation of “Hold” from Analysts https://t.co/RlKtJi7MqS #stocks August 15th 2018, 12:08pm |
|
@MareaInformativ Enanta Pharmaceuticals Inc $ENTA Receives Average Recommendation of “Hold” from Analysts https://t.co/K9ePLkZa5L August 15th 2018, 12:08pm |
|
@MareaInformativ AlphaMark Advisors LLC Has $1.29 Million Stake in Enanta Pharmaceuticals Inc $ENTA https://t.co/QIlI0UdNCM August 15th 2018, 6:08am |
|
@AmericanBanking Enanta Pharmaceuticals $ENTA Given a $100.00 Price Target at Oppenheimer https://t.co/ZlobVOun6K #stocks August 14th 2018, 7:08pm |
 |
@TheMarketsDaily Enanta Pharmaceuticals $ENTA Given a $100.00 Price Target by Oppenheimer Analysts https://t.co/k46qhIIQA0 August 14th 2018, 7:08pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2018. All rights reserved.